UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031120
Receipt number R000035542
Scientific Title Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor
Date of disclosure of the study information 2018/02/02
Last modified on 2021/03/22 15:27:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor

Acronym

Retrospective Study of thoracic tumor

Scientific Title

Retrospective Study on Clinicopathologic Features and Prognosis of thoracic tumor

Scientific Title:Acronym

Retrospective Study of thoracic tumor

Region

Japan


Condition

Condition

Chest tumor which is represented by lung cancer, thymus epithelium tumor, and malignant pleural mesothelioma

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Using existing administrative data, we analize the clinicopathologic characteristic, an effect, safety of the treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

To explore factors related with curative effect, convalescence, complications.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient who the diagnosis of chest tumor, an operation, chemotherapy, radiotherapy, relaxation care were carried out in the Jikei-Daisan Hospital until December 31, 2017.

Key exclusion criteria

The patients who refused to participate in our study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Naoki
Middle name
Last name Takasaka

Organization

The Jikei Daisan Hospital, Japan

Division name

Division of Respirology, Department of Internal Medicine

Zip code

201-8601

Address

4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan

TEL

03-3480-1151

Email

ntakasak@gmail.com


Public contact

Name of contact person

1st name Naoki
Middle name
Last name Takasaka

Organization

The Jikei Daisan Hospital, Japan

Division name

Division of Respirology, Department of Internal Medicine

Zip code

201-8601

Address

4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan

TEL

03-3480-1151

Homepage URL


Email

ms97-seki@jikei.ac.jp


Sponsor or person

Institute

The Jikei Daisan Hospital, Japan

Institute

Department

Personal name



Funding Source

Organization

The Jikei Daisan Hospital, Japan

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei Daisan Hospital, Japan

Address

4-11-1 Izumihoncho, Komae, Tokyo 201-8601, Japan

Tel

03-3480-1151

Email

rinri@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京慈恵会医科大学附属第三病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 02 Month 23 Day

Date of IRB

2018 Year 05 Month 15 Day

Anticipated trial start date

2018 Year 12 Month 31 Day

Last follow-up date

2020 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 12 Month 31 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2021 Year 12 Month 31 Day


Other

Other related information

Retrospective analysis


Management information

Registered date

2018 Year 02 Month 02 Day

Last modified on

2021 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035542


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name